Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 294

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 294
---
 among Regentis Biomaterials Ltd. and the lender parties thereto |
|:-------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.16* |     | Settlement Agreement dated December 1, 2024, by and between Regentis Biomaterials Ltd. and Eli Hazum                                              |
| 23.1*  |     | Consent                                                                                                                                           
 of Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm                         |
| 23.2*  |     | Consent                                                                                                                                           
 of Doron Tikotzky Kantor Gutman & Amit Gross (included in Exhibit 5.1)                                                                            |
| 23.3*  |     | Consent of Greenberg Traurig, LLP (included in Exhibit 5.2)                                                                                       |
| 24.1*  |     | Power                                                                                                                                             
 of Attorney (included in signature pages of Registration Statement)                                                                               |
| 99.1*  |     | Consent of Dr. Susan Alpert as Director Nominee                                                                                                   |
| 99.2*  |     | Consent of Pini Ben-Elazar as Director Nominee                                                                                                    |
| 99.3*  |     | Consent of Efraim Cohen-Arazi as Director Nominee                                                                                                 |
| 107*   |     | Filing                                                                                                                                            
 Fee Table                                                                                                                                         |

| * | Filed herewith.                                                                    |
| + | Indicates a management contract or any compensatory plan, contract or arrangement. |

<div align='center'>II-8

SIGNATURES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form F-1 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Herzliya, Israel on this 5 day of May, 2025.

| REGENTIS BIOMATERIALS LTD. |                         |
| By:                        | /s/ Dr. Eli Hazum       |
|                            | Dr. Eli Hazum,          |
|                            | Chief Executive Officer |

Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature         
 /s/ Dr.